Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Kestra Medical Technologies, Ltd. (KMTS)

29.69 -0.92 (-3.01%)
At close: October 30 at 4:00:02 PM EDT
29.69 0.00 (0.00%)
After hours: October 30 at 4:00:16 PM EDT
Trade KMTS on Coinbase

Key Executives

Amounts are as of December 31, 2026 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name Title Pay Exercised Year Born
Mr. Brian Webster
Founder, President, CEO & Director 1.78M -- 1964
Ms. Traci S. Umberger
Co-Founder, General Counsel, Chief Administrative Officer, Secretary & Director 953.76k -- 1963
Mr. Vaseem Mahboob
Chief Financial Officer 836.6k -- 1969
Mr. Gordon Teddy
Chief Information Officer 21.16k -- --
Mr. Alfred J. Ford Jr.
Chief Commercial Officer 884.42k -- 1971
Mr. Neil Bhalodkar
Vice President of Investor Relations -- -- --
Ms. Debra Schotz
Senior Vice President of Marketing -- -- 1970
Mr. Jeffrey Laub
Senior Vice President of Operations -- -- 1971
Mr. Timothy P. Moran
Chief Business Officer -- -- 1972
Mr. R. Curtis Kopf
Senior Vice President of Customer Experience -- -- 1966

Kestra Medical Technologies, Ltd.

3933 Lake Washington Blvd NE
Suite 200
Kirkland, WA 98033
United States
425 279 8002 https://kestramedical.com
Sector: 
Healthcare
Full Time Employees: 
443

Description

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease through connected monitoring, therapeutic intervention, and data-driven clinical insights. The company also develops and commercializes Cardiac Recovery System platform, an integrated cardiac recovery ecosystem designed to support patients at elevated risk of sudden cardiac arrest (SCA) during vulnerable periods of recovery. Its platform provides ASSURE Wearable Cardioverter Defibrillator (WCD), which continuously monitors patient heart rhythms and automatically delivers defibrillation therapy when life-threatening ventricular arrhythmias are detected; digital patient engagement and clinical workflow solutions designed to improve patient adherence, support care coordination, and provide actionable clinical insights throughout the recovery process; and integrated platform generates continuous cardiac rhythm data and clinically actionable insights. Kestra Medical Technologies, Ltd. was founded in 2014 and is based in Kirkland, Washington.

Corporate Governance

Kestra Medical Technologies, Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

December 14, 2026 at 9:00 PM UTC

Kestra Medical Technologies, Ltd. Earnings Date

Recent Events

September 14, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

September 10, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

July 28, 2026 at 12:00 AM UTC

DEFA14A: Proxy Statements

July 14, 2026 at 12:00 AM UTC

10-K: Periodic Financial Reports

April 1, 2026 at 12:00 AM UTC

S-3ASR: Offering Registrations

March 18, 2026 at 12:00 AM UTC

S-8: Offering Registrations

March 17, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

December 11, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

December 4, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

December 2, 2025 at 12:00 AM UTC

S-1MEF: Offering Registrations

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: